bevacizumab,atezolizumab
roche
['atezo', ' bev ', 'hcc']
i hope we wait for os data for making adjuvant atezo plus bev for hcc as part of gudilelines. not practice changing as of now . and should not be practice changing, if there is no os . let's keep the bar of approval high #asco23 
Oncology care , to give or not to give chemo , data analysis , oncology pharamocovigilance , enthusiastic critic, twitts are not twists